The spectrum of mutated genes found in NSAID users and non-users was highly heterogeneous, consistent with previous WGS and WES studies in EA that found very few genes mutated at high frequencies across cancers, with the exception of TP53 [5, 10–14, 16]. Here, TP53 is linked to cancer.